Last Updated: May 10, 2026

Suppliers and packagers for acetaminophen


✉ Email this page to a colleague

« Back to Dashboard


acetaminophen

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Aspiro ACETAMINOPHEN acetaminophen SOLUTION;INTRAVENOUS 216617 ANDA Camber Pharmaceuticals, Inc. 31722-205-10 10 VIAL, SINGLE-DOSE in 1 CARTON (31722-205-10) / 100 mL in 1 VIAL, SINGLE-DOSE (31722-205-31) 2022-07-27
Aspiro ACETAMINOPHEN acetaminophen SOLUTION;INTRAVENOUS 216617 ANDA Camber Pharmaceuticals, Inc. 31722-205-24 24 VIAL, SINGLE-DOSE in 1 CARTON (31722-205-24) / 100 mL in 1 VIAL, SINGLE-DOSE (31722-205-31) 2022-07-27
B Braun Medical ACETAMINOPHEN acetaminophen SOLUTION;INTRAVENOUS 204957 NDA B. Braun Medical Inc. 0264-4050-80 24 CONTAINER in 1 CASE (0264-4050-80) / 50 mL in 1 CONTAINER 2021-02-18
B Braun Medical ACETAMINOPHEN acetaminophen SOLUTION;INTRAVENOUS 204957 NDA B. Braun Medical Inc. 0264-4050-90 24 CONTAINER in 1 CASE (0264-4050-90) / 50 mL in 1 CONTAINER 2021-02-18
B Braun Medical ACETAMINOPHEN acetaminophen SOLUTION;INTRAVENOUS 204957 NDA B. Braun Medical Inc. 0264-4050-80 24 CONTAINER in 1 CASE (0264-4050-80) / 50 mL in 1 CONTAINER 2023-10-10
B Braun Medical ACETAMINOPHEN acetaminophen SOLUTION;INTRAVENOUS 204957 NDA B. Braun Medical Inc. 0264-4050-90 24 CONTAINER in 1 CASE (0264-4050-90) / 50 mL in 1 CONTAINER 2023-10-10
B Braun Medical ACETAMINOPHEN acetaminophen SOLUTION;INTRAVENOUS 204957 NDA B. Braun Medical Inc. 0264-4100-90 24 CONTAINER in 1 CASE (0264-4100-90) / 100 mL in 1 CONTAINER 2021-02-18
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for acetaminophen

Last updated: April 25, 2026

Who Supplies Acetaminophen to the Pharmaceutical Market?

Acetaminophen (paracetamol) is a high-volume, commodity Active Pharmaceutical Ingredient (API) with a deep global supply base. Supplier qualification typically splits into two lanes: (1) API manufacturers of record for acetaminophen (API) and (2) finished-dose manufacturers that package acetaminophen tablets, capsules, and combination products under branded or private-label programs.

Which companies manufacture acetaminophen API?

Below are established, widely cited API and bulk-drug producers that have published acetaminophen capabilities and supply into global pharmaceutical markets.

Global API and bulk-drug manufacturers (representative)

Company HQ / Region (public) Typical role in market Product form commonly supplied
Jiangsu Hengrui Medicine (Hengrui) China API and pharmaceutical intermediate supply Acetaminophen API (paracetamol) (supplier presence in China bulk market)
Shandong Lukang Pharmaceutical China API manufacturing Acetaminophen API (paracetamol)
Ningbo Sansheng Pharmaceutical China API manufacturing Acetaminophen API
Nantong Jiuzhou Pharmaceutical China API supply Acetaminophen API
Hangzhou Keyun Pharmaceutical China API supply Acetaminophen API
Hubei Jinghong Pharmaceutical China API supply Acetaminophen API
Sudeep Pharma Chem India API manufacturing Acetaminophen API
Borregaard (downstream only; not an acetaminophen API producer) Europe Not relevant for acetaminophen Not a direct acetaminophen supplier (listed only to avoid misattribution)

Source basis: acetaminophen API supplier listings are routinely published via chemical and API distributor databases and industry supplier directories that aggregate vendor capabilities for procurement and qualification workflows (example sources cited below). [1]-[3]

Which finished-dose manufacturers supply acetaminophen tablets and capsules?

Acetaminophen finished-dose production is split across brand owners, large global generic firms, and contract manufacturers (CMOs) that fill-and-finish for private label.

Representative finished-dose and generic manufacturers (representative)

Company Common packaging footprint Typical role Drug form
Teva U.S. and global Generic and branded alternatives Tablets, capsules
Lupin U.S. and global Generic Tablets, combination products
Sandoz Global Generic Tablets, caplets
Mylan (Viatris) Global Generic Tablets, extended supply cycles
Dr. Reddy’s Global Generic Tablets, combination products
Amneal U.S. Generic Tablets, capsules

Source basis: manufacturer participation in acetaminophen dosage forms is visible through drug product label coverage and generic product presence in public drug databases. [4]-[6]

How do procurement teams validate acetaminophen suppliers?

Qualification centers on regulatory compliance and manufacturing documentation, not marketing claims. For acetaminophen, procurement workflows typically enforce these controls:

Quality documentation that drives supplier acceptance

  • GMP compliance: Evidence that API and/or finished-dose manufacturing is under current Good Manufacturing Practice (cGMP).
  • Regulatory filings: Batch- and site-specific information that supports commercial supply.
  • Third-party audits: Qualification packages and audit outcomes aligned to risk.

Regulatory and listing checkpoints

  • FDA drug product and label databases for finished-dose products and distributor attribution. [4]
  • FDA drug establishment and manufacturing site records (where available) for site-level inspection and compliance history. [7]
  • API supplier listings through public industry aggregators used in early-stage vendor screening and RFP response routing. [1]-[3]

What supplier categories matter most for acetaminophen procurement?

Acetaminophen sourcing is usually managed through one of these procurement structures:

1) Direct API procurement

Used when a company manufactures its own finished dose or operates a contract fill strategy with API supplied by the client.

2) Finished-dose contract supply

Used when the company owns the packaging/labeling strategy but delegates manufacturing to a contract manufacturer.

3) Private-label programs

Used when volume is high and commercial launch timing is short. Supplier selection is driven by packaging line readiness and regulatory dossier strength.

Supplier landscape patterns specific to acetaminophen

Concentration in Asia for API

The acetaminophen API supply base is heavily represented by China- and India-based manufacturers, with multiple producers competing on cost, batch reliability, and dossier acceptance.

Multiple supplier qualification is standard

Acetaminophen’s high sales volume and supply exposure commonly lead to multi-sourcing to reduce risk from single-site disruptions.

Key Takeaways

  • Acetaminophen is a commodity API with a broad supplier base; procurement usually sources through China and India API manufacturers and pairs API supply with either in-house finishing or contract fill-and-finish.
  • Supplier selection should be anchored to GMP status, site-level regulatory records, and product dossier traceability, not directory presence alone.
  • Finished-dose supply is served by large generics manufacturers and contract manufacturing networks, with product label databases and regulatory listings used to map real-world sourcing footprints.

FAQs

1) Is acetaminophen (paracetamol) sourced mostly as an API or as finished tablets?
Both. High-volume brands and generics frequently procure API directly and manufacture tablets/caplets, while private-label programs often procure finished-dose from contract manufacturers.

2) What regions dominate acetaminophen API manufacturing?
Asia dominates, with multiple China- and India-based manufacturers supplying acetaminophen API into global markets. [1]-[3]

3) How do buyers verify an acetaminophen supplier’s GMP standing?
Through cGMP documentation tied to the specific manufacturing site, supported by regulatory inspection records where available, and audit results for dossier acceptance. [7]

4) Are there many suppliers for acetaminophen versus niche APIs?
Yes. Acetaminophen’s market depth creates a large vendor set, enabling multi-sourcing strategies for supply continuity.

5) What sources are most useful for mapping actual acetaminophen product supply?
FDA label and product databases for finished-dose footprints, and industry supplier directories for initial API vendor screening. [4]-[6]


References (APA)

[1] ChemBK. (n.d.). Acetaminophen manufacturers, suppliers, exporters, wholesalers. Retrieved April 26, 2026, from https://www.chembk.com/
[2] ChemicalBook. (n.d.). Acetaminophen suppliers. Retrieved April 26, 2026, from https://www.chemicalbook.com/
[3] Alibaba. (n.d.). Acetaminophen (paracetamol) API suppliers. Retrieved April 26, 2026, from https://www.alibaba.com/
[4] U.S. Food and Drug Administration. (n.d.). Drugs@FDA. Retrieved April 26, 2026, from https://www.accessdata.fda.gov/scripts/cder/daf/
[5] U.S. Food and Drug Administration. (n.d.). Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Retrieved April 26, 2026, from https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
[6] U.S. National Library of Medicine. (n.d.). DailyMed. Retrieved April 26, 2026, from https://dailymed.nlm.nih.gov/dailymed/
[7] U.S. Food and Drug Administration. (n.d.). OpenFDA Drug Establishments (where available) and related public inspection and establishment information. Retrieved April 26, 2026, from https://open.fda.gov/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.